Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-27

Clinical Trial Update: Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II trial of everolimus (RAD001) in previously treated small cell lung cancer; results from the study were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Afinitor (everolimus) (everolimus)

Snippet

Sponsor: Ahmad Tarhini | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-02-27